Physician profile
Mark S Grogan
NPI 1306909379
$1,215.65
in general payments reported to CMS, 2019-2025
13 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,059 · 2020: $84.01 · 2021: $13.68 · 2024: $58.59.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $58.59.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $58.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $251.65 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $206.05 | 2019-2024 | |
| Amgen INC. | $203.97 | 2019 | |
| Janssen Pharmaceuticals, INC | $190.49 | 2019 | |
| Pfizer INC. | $104.56 | 2019-2024 | |
| Lundbeck LLC | $57.91 | 2019 | |
| Alnylam Pharmaceuticals INC. | $47.01 | 2019 | |
| Sanofi-Aventis U.S. LLC | $40.46 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $35.14 | 2019 | |
| Medtronic Vascular, INC. | $27.07 | 2020 | |
| Boston Scientific Corporation | $20.56 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $17.31 | 2019 | |
| Amarin Pharma, INC. | $13.47 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Grogan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.